Adial Pharmaceuticals Inc (ADIL) Stock Price, Quote & News

Company Profile

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen...

Industry: Biotechnology

Sector: Healthcare

Phone: 804 487 8196

Website: www.adial.com

Address:

4870 Sadler Road, Suite 300, Glen Allen, United States

gracehh Aug. 3 at 10:30 PM

$ADIL $CLW Watchlist71

0 · Reply

TheProbieAnalyst Aug. 3 at 8:13 PM

$ADIL

0 · Reply

IN0V8 Aug. 3 at 3:37 PM

$ADIL Watch / Opportunity Alliance Global Partners initiates with buy rating Alliance Global Partners initiates with PT $11 Leerink Partners raises target price to $73 from $62

0 · Reply

gracehh Jul. 30 at 10:27 PM

$MNDY $ADIL watchlist1

0 · Reply

Vibration Jul. 29 at 7:49 PM

$ADIL running!

0 · Reply

Patrik605 Jul. 24 at 2:22 PM

$ADIL It seems to me that they are not even able to come to work in time to release the news before the market opens... That is why they often release it during the open market. Or I can't explain it. I understand that coming to work at 10 is better than at 8. Then I'm not surprised that everything takes so extremely long.

0 · Reply

Patrik605 Jul. 24 at 2:12 PM

$ADIL This management is really working at supersonic speed. It's been a year since they wanted to start phase 3 by the end of 2025! Carry receives a relatively high salary of 1 million USD per year. And that's not all employees. According to Adial's estimate, the first phase of the study could cost 7-12 million... So calculate the almost fruitless losses yourself...

0 · Reply

Patrik605 Jul. 23 at 2:19 PM

$ADIL Will we finally see some progress? It's been a year... With almost nothing.

0 · Reply